市場調査レポート
商品コード
1255233
細胞健康スクリーニング市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年:検査タイプ別、サンプル別、採取部位別、地域別セグメントCellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Test Type, By Sample, By Site of Collection, By Region |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
細胞健康スクリーニング市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年:検査タイプ別、サンプル別、採取部位別、地域別セグメント |
出版日: 2023年04月01日
発行: TechSci Research
ページ情報: 英文 115 Pages
納期: 2~3営業日
|
細胞健康スクリーニングの世界市場は、予測期間中に目覚ましい成長を遂げると予想されています。
これは、座りがちなライフスタイルの増加や人口の高齢化により、糖尿病や肥満などの疾病が発生しているためと考えられます。また、健康的な食生活や運動など、健康的な生活を維持するためのテロメアパフォーマンスプログラムの採用が増加しており、健康寿命の重要性の高まりや顧客への直接アプローチの採用が増加していることから、予測期間中に大きな成長が見込まれています。さらに、さまざまな種類の病気や肥満にかかりやすい老年人口が世界中で増加していることから、細胞健康スクリーニングの需要がさらに高まり、2028年までの市場成長を促進すると予想されます。そのほか、さまざまな慢性疾患とともに、世界中で悪い食習慣によるがん患者が増加していることも、予測期間中に細胞健康スクリーニングの需要を高めています。今年、米国では推定66,470人(男性48,520人、女性17,950人)が頭頸部がんと診断される見込みです。同様に、新薬やサプリメントを作るためのさまざまな前臨床研究のための研究開発プロジェクトが増加していることも、予測期間中の細胞健康スクリーニング市場の需要を高めています。
テロメアパフォーマンスプログラムの採用が増加し、予測期間中に世界の細胞健康スクリーニング市場に有利な成長をもたらすと期待されています。慢性疾患の有病率の増加により、健康的なライフスタイルを送ることへの需要が高まっており、これがさらに長年にわたって市場成長を促進すると予想されます。2001年に世界で発生した全疾患の約46%、5,650万人の死亡者のうち60%が慢性疾患によるものでした。細胞の老化の変化には、身体活動、睡眠、心理的障害など、さまざまな要因が関係しています。また、過度の喫煙や飲酒の習慣は、さまざまなタイプの慢性疾患を生み出す可能性があり、細胞の健康診断がさらに求められることになります。テロメア検査の使用は、臨床医に代謝性疾患や遺伝性疾患に関する洞察を提供し、早期診断と患者のためのタイムリーな個別化治療計画を提供します。しかし、細胞スクリーニングに関する認識と調査の高まりは、キットテストの需要の上昇につながり、これがさらに予測期間中の市場成長を押し上げると予想されます。米国国立がん研究所によると、2018年、米国で新たに診断されたがん患者は1,735,350人でした。
人口増加による糖尿病や肥満などの生活習慣病、過度のアルコール摂取、タバコの使用、運動不足、高体重指数、果物や野菜の摂取量の少なさなどの有病率の増加は、予測期間中に市場を有利に成長させるとさらに期待されています。老年人口の増加とその結果、細胞健康スクリーニングの需要が高まり、市場の成長が促進されると予想されます。2020年、米国では推定1,806,590人のがん患者が新たに診断され、606,520人がこの病気で死亡しています。
与えられた市場データをもとに、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です。
The Global Cellular Health Screening Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing sedentary lifestyle and an aging population, consequently resulting in diseases like diabetes and obesity. Additionally, the growing adoption of telomere performance programs for maintaining a healthy life, such as maintaining a healthy weight with healthy eating, exercise regularly along with the growing importance of healthy life expectancy and the growing adoption of direct to customer approach, is expected to create significant growth during the forecasted period. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cellular health screening, thereby fuelling market growth through 2028. Besides, the growing number of cancer patients due to bad food habits across the globe, along with different chronic diseases, is increasing the demand for cellular health screening during the forecast period. This year, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States. Similarly, an increase in research and development projects for different pre-clinical studies can make new drugs or supplements enhance the demand for the cellular health screening market in the forecast period.
Increasing adoption of telomere performance programs is expected to create lucrative growth for the global cellular health screening market during the forecast period. Due to the increasing prevalence of chronic diseases, the demand for leading a healthy lifestyle has increased, which is further expected to drive market growth over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions. Different factors are responsible for changes in cellular aging, such as physical activity, sleep, and psychological disorders. Also, excessive smoking and drinking habits can create different types of chronic diseases, which will further demand cellular health screening. The usage of telomere tests provides clinicians with insights into metabolic and genetic diseases with early diagnosis and timely personalized treatment plans for patients. However, growing awareness and research about cellular screening have led to a rise in the demand for kit tests, which is further expected to boost the market growth during the forecast period. According to the National Cancer Institute, in 2018, there were 1,735,350 new cancer cases diagnosed in the United States.
The increasing prevalence rate of lifestyle disorders such as diabetes and obesity, excessive alcohol consumption, tobacco use, low physical activity, high body mass index, and low intake of fruits and vegetables because of a growing population is further expected to create a lucrative growth of the market during the forecast period. The growing geriatric population and its consequent growth are expected to raise the demand for cellular health screening, in turn propelling the growth of the market. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the United States, and 606,520 people died from the disease.
The global cellular health screening market can be segmented by test type, sample, site of collection, and by region. Based on test type, the market can be divided into Single Test Panels v/s Multi Test Panels. Based on the sample, the market can be segmented into Blood, Saliva, Urine, and Others. Based on the site of collection, the market can be differentiated into homes, Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global cellular health screening market on account of the growing demand for maintaining healthy life expectancy, along with the growing adoption of new technology in the country.
Telomere Diagnostics, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, SpectraCell Laboratories, Inc., Cell Science Systems Corporation, Immundiagnostik AG, Repeat Diagnostics, Inc., OPKO Health, Inc., Genova Diagnostics, Inc., Titanovo, Inc. are some of the leading players operating in the Global Cellular Health Screening Market.
In this report, global cellular health screening systems market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Cellular Health Screening Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: